Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

NCT00030082 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Liver Cancer
Metastatic Cancer

Interventions

DRUG: isolated perfusion
DRUG: melphalan

Sponsor

National Cancer Institute (NCI)